Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 814,500 | 805,500 | 794,900 | 687,500 | 572,600 |
| Cost of Goods | 13,800 | 17,600 | 14,000 | 11,300 | 9,200 |
| Gross Profit | 800,700 | 787,900 | 780,900 | 676,200 | 563,400 |
| Operating Expenses | 608,100 | 577,600 | 541,900 | 530,900 | 540,000 |
| Operating Income | 193,400 | 210,900 | 239,000 | 145,600 | 23,600 |
| Other Income | 53,400 | 28,500 | 52,800 | 13,900 | -8,900 |
| Pre-tax Income | 246,800 | 239,400 | 291,800 | 159,500 | 14,700 |
| Income Tax | 48,900 | 85,700 | 82,300 | 52,000 | 6,800 |
| Net Income Continuous | 197,900 | 153,700 | 209,500 | 107,500 | 7,900 |
| Net Income | $197,900 | $153,700 | $209,500 | $107,500 | $7,900 |
| EPS Basic Total Ops | 1.97 | 1.53 | 2.11 | 1.09 | 0.08 |
| EPS Basic Continuous Ops | 1.97 | 1.54 | 2.11 | 1.09 | 0.08 |
| EPS Diluted Total Ops | 1.91 | 1.49 | 2.04 | 1.06 | 0.08 |
| EPS Diluted Continuous Ops | 1.91 | 1.48 | 2.04 | 1.06 | 0.08 |
| EPS Diluted Before Non-Recurring Items | 1.41 | 1.43 | 2.04 | 1.06 | 0.08 |
| EBITDA(a) | $200,700 | $205,700 | $246,700 | $152,900 | $31,200 |